10-K · August 18, 2026
AXIL delivered strong fiscal 2026 growth, with revenue up 17.5% to $30.8 million and diluted EPS rising to $0.33, driven by rapid expansion of hearing products into big-box and specialty retail. The strategy is…
Earnings analysis · 10-Q
Filed October 6, 2026 · Our reading of the company's report
The latest report
The provided 10-Q excerpt is limited to controls, legal proceedings, risk factors, and other information; it does not include the income statement, balance sheet, cash flow statement, segment data, or MD&A needed to…
The provided 10-Q excerpt is limited to controls, legal proceedings, risk factors, and other information; it does not include the income statement, balance sheet, cash flow statement, segment data, or MD&A needed to assess quarterly financial trends. Disclosure controls were deemed effective as of August 31, 2026, and no material changes to internal control were identified during the quarter. Management reported no material changes to the risk factors in the May 31, 2026 Form 10-K, while noting that litigation outcomes remain uncertain.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Management concluded that disclosure controls and procedures were effective as of August 31, 2026.
The company reported no changes during the quarter ended August 31, 2026 that materially affected, or were reasonably likely to materially affect, internal control over financial reporting.
No unregistered securities were issued during the first quarter of fiscal 2027.
Management states that legal proceedings are inherently uncertain and that a particular matter or combination of matters could be material for a period, despite individual accrued matters being immaterial. The filing states the assessment applies to the year ended May 31, 2026.
The company says there is no assurance that legal expenses, liabilities, or damages will be covered by insurance or remain within recognized amounts; the filing reports no material change to previously disclosed risk factors as of October 6, 2026.
The provided 10-Q excerpt contains no quantitative revenue or EPS outlook. It also does not provide updated operating, liquidity, or capital-spending guidance.
AXIL delivered strong fiscal 2026 growth, with revenue up 17.5% to $30.8 million and diluted EPS rising to $0.33, driven by rapid expansion of hearing products into big-box and specialty retail. The strategy is…
AXIL reported quarterly revenue of $7,294,030 (up $371,663 vs. prior-year quarter) but showed margin compression and EPS decline. Gross profit was $5,041,821 (gross margin ~69.1%), operating income fell to $214,239…
AXIL reported quarterly sales of $7,732,574 and diluted EPS of $0.08 for the three months ended November 30, 2024. Revenue and gross profit declined versus the prior-year quarter, but operating cash flow was strong at…
AXIL reported sales of $5,851,272 and a net loss of $109,805 (diluted EPS $(0.02)) for the three months ended August 31, 2024. Operating cash flow was strong at $897,318 and cash ended the period at $4,148,724, but…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.